SEVERE INTRAOCULAR PRESSURE ELEVATION FOLLOWING INTRAVITREAL RANIBIZUMAB (LUCENTIS) INJECTION FOR WET AGE-RELATED MACULAR DEGENERATION

被引：0
|
作者：
Reis, Gustavo [1 ]
Schendel, Steven [1 ]
Goldberg, Ivan [1 ,2 ]
Lim, Ridia [1 ,2 ]
Chua, Brian E. [1 ,2 ,3 ]
Lee, Anne [1 ,2 ]
Martins, Alessandra [1 ,2 ]
Higgins, Ralph [1 ,2 ]
Grigg, John [1 ,2 ,4 ]
Clement, Colin I. [1 ,2 ]
机构：
[1] Sydney Eye Hosp, Glaucoma Unit, Sydney, NSW 2000, Australia
[2] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia
[3] Macquarie Univ, Sch Adv Med, Sydney, NSW 2109, Australia
[4] Save Sight Inst, Sydney, NSW 2000, Australia
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2013年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [41] Intravitreal Injection of Ranibizumab for Treatment of Age-Related Macular Degeneration: Effects on Serum VEGF Concentration
    Gu, Xiaoya
    Yu, Xiaobing
    Dai, Hong
    CURRENT EYE RESEARCH, 2014, 39 (05) : 518 - 521
  • [42] Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration
    Shin, Joo Youn
    Kwon, Kye Yoon
    Byeon, Suk Ho
    ACTA OPHTHALMOLOGICA, 2015, 93 (06) : 524 - 532
  • [43] Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients
    Min, Ji Sang
    Jung, Hyun Chul
    Suh, Ji Young
    Kwon, Yoon Hyung
    JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2016, 57 (11): : 1738 - 1744
  • [44] Retinal Blood Flow in Response to an Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration
    Micieli, J. A.
    Wong, T.
    Lam, W. -C.
    Brent, M. H.
    Devenyi, R. G.
    Hudson, C.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [45] Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
    Karaca, Umut
    Durukan, Ali Hakan
    Erdurman, Fazil Cuneyt
    Sobaci, Gungor
    Bayraktar, Mehmet Zeki
    TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2012, 42 (01): : 25 - 29
  • [46] Effect of Intravitreal Ranibizumab on Corneal Endothelium in Age-Related Macular Degeneration
    Perez-Rico, Consuelo
    Benitez-Herreros, Javier
    Castro-Rebollo, Maria
    Gomez-SanGil, Yanira
    Germain, Francisco
    Angeles Montes-Mollon, Maria
    Angel Teus, Miguel
    CORNEA, 2010, 29 (08) : 849 - 852
  • [47] Early treatment of exudative age-related macular degeneration with ranibizumab (Lucentis®). The key to success
    Matthe, E.
    Sandner, D.
    OPHTHALMOLOGE, 2011, 108 (03): : 237 - 243
  • [48] Intraocular Inflammation Following Intravitreal Injection of Anti-VEGF Medications for Neovascular Age-Related Macular Degeneration
    Knickelbein, Jared E.
    Chew, Emily Y.
    Sen, H. Nida
    OPHTHALMIC EPIDEMIOLOGY, 2016, 23 (02) : 69 - 70
  • [49] Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness Analysis
    Hernandez, Luis
    Lanitis, Tereza
    Cele, Clifford
    Toro-Diaz, Hector
    Gibson, Andrea
    Kuznik, Andreas
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 608 - 616
  • [50] Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis)
    G C Scalzo
    F Campagna
    G Randazzo
    G Scorcia
    BMC Geriatrics, 10 (Suppl 1)
12345